Keywords: اینترفرون بتا 1a; RRMS; Disease activity free status; Clinical trial; Interferon beta-1a; Glatiramer acetate;
مقالات ISI اینترفرون بتا 1a (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: اینترفرون بتا 1a; MS; multiple sclerosis; IFN-beta-1a; interferon beta-1a; RRMS; relapsing-remitting multiple sclerosis; EDSS; expanded disability status scale; MRI; magnetic resonance imaging; IL; interleukin; sCD40L; soluble CD40-ligand; sTNF-R; soluble tumor necrosis fa
Keywords: اینترفرون بتا 1a; Multiple sclerosis; Disability progression; Interferon beta-1a; EDSS;
Matching-adjusted comparisons demonstrate better clinical outcomes with SC peginterferon beta-1a every two weeks than with SC interferon beta-1a three times per week
Keywords: اینترفرون بتا 1a; AE; adverse event; ARR; annualized relapse rate; CDW; confirmed disability worsening; CI; confidence interval; DMT; disease-modifying therapy; EDSS; Expanded Disability Status Scale; IFN; interferon; IM; intramuscular; IPD; individual patient data; NEDA;
Immune regulatory effects of high dose vitamin D3 supplementation in a randomized controlled trial in relapsing remitting multiple sclerosis patients receiving IFNβ; the SOLARIUM study
Keywords: اینترفرون بتا 1a; BFA; brefeldin A; BMI; body mass index; Breg; regulatory B cell; CNS; central nervous system; EDSS; expanded disability status scale; GMCSF; granulocyte macrophage colony-stimulating factor; HC; healthy control; IFNβ-1a; interferon beta-1a; IL; interleuk
Can aerobic exercise alleviate flu-like symptoms following interferon beta-1a injections in patients with multiple sclerosis?
Keywords: اینترفرون بتا 1a; Multiple sclerosis; Aerobic exercise; Flu-like symptoms; Interferon beta-1a; Cytokines; Exercise therapy;
Long-term efficacy and safety of intramuscular interferon beta-1a: Randomized postmarketing trial of two dosing regimens in Japanese patients with relapsing-remitting multiple sclerosis
Keywords: اینترفرون بتا 1a; ARR; annualized relapse rate; CI; confidence interval; EDSS; Expanded Disability Status Scores; Gd+; gadolinium-enhancing; IFN beta; interferon beta; IFN beta-1a; interferon beta-1a; IM; intramuscular; MedDRA; Medical Dictionary for Regulatory Activities;
Tumefactive multiple sclerosis and hepatitis C virus 2a/2C infection: Dual benefit of long-term interferon beta-1a therapy?
Keywords: اینترفرون بتا 1a; Tumefactive multiple sclerosis; Acute disseminated encephalomyelitis; Hepatitis C virus infection; HCV genotype 2a/2c; Interferon beta-1a; Peginterferon;
Effect of switching from intramuscular interferon β-1a to oral fingolimod on time to relapse in patients with relapsing-remitting multiple sclerosis enrolled in a 1-year extension of TRANSFORMS
Keywords: اینترفرون بتا 1a; DMT; disease modifying therapy; EDSS; Expanded Disability Status Scale; IFNβ-1a; interferon beta-1a; IM; intramuscular; MS; multiple sclerosis; TRANSFORMS; Trial Assessing Injectable Interferon Versus Fingolimod Oral in Relapsing-Remitting Multiple Scl
Interferon-beta-1a treatment has a positive effect on quality of life of relapsing-remitting multiple sclerosis: Results from a longitudinal study
Keywords: اینترفرون بتا 1a; Multiple sclerosis; Quality of life; Interferon beta-1a; EDSS; MSQoL-54; Relapse;
Efficacy and safety of subcutaneous interferon beta-1a in relapsing–remitting multiple sclerosis: Further outcomes from the IMPROVE study
Keywords: اینترفرون بتا 1a; Relapsing–remitting multiple sclerosis; Magnetic resonance imaging; Interferon beta-1a; Efficacy; Safety; Randomized controlled trial
Adherencia subóptima al tratamiento en la esclerosis múltiple
Keywords: اینترفرون بتا 1a; Esclerosis múltiple; Interferón beta 1-a; Interferón beta 1-b; Acetato de glatirámero; Adherencia terapéutica; Multiple sclerosis; Interferon beta-1a; Interferon beta-1b; Glatiramer acetate; Treatment adherence;
Efficacy of vitamin D3 as add-on therapy in patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta-1a: A Phase II, multicenter, double-blind, randomized, placebo-controlled trial
Keywords: اینترفرون بتا 1a; Multiple sclerosis; Vitamin D; Interferon beta-1a; 25-Hydroxyvitamin D; 1,25-Dihydroxyvitamin D; Clinical trial; Biomarker; SOLAR;
Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosis
Keywords: اینترفرون بتا 1a; Natalizumab; Interferon beta-1a; Multiple sclerosis; Integrin; Adhesion molecule inhibitor; Treatment; Magnetic resonance imaging
The implications of immunogenicity for protein-based multiple sclerosis therapies
Keywords: اینترفرون بتا 1a; Binding antibodies; Disease-modifying therapy; Glatiramer acetate; Interferon beta-1a; Interferon beta-1b; Multiple sclerosis; Natalizumab; Neutralizing antibodies
Assessment of the immunogenicity of different interferon beta-1a formulations using ex vivo T-cell assays
Keywords: اینترفرون بتا 1a; Interferon beta-1a; Multiple sclerosis; New formulation; Immunogenicity; T-cell; Dendritic cell
Interferon beta-1a therapy enhances CD4+ regulatory T-cell function: An ex vivo and in vitro longitudinal study in relapsing−remitting multiple sclerosis
Keywords: اینترفرون بتا 1a; Ex vivo; In vitro; Interferon beta-1a; Regulatory T-cell; Relapsing−remitting multiple sclerosis